NCT00402961

Brief Summary

The purpose of this study is to see whether acupuncture may help patients recover from colon cancer surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Oct 2006

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 23, 2006

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
Last Updated

October 12, 2015

Status Verified

October 1, 2015

Enrollment Period

6.3 years

First QC Date

November 22, 2006

Last Update Submit

October 9, 2015

Conditions

Keywords

AcupuncturePost-Colectomy IleusAbdominal SurgeryColon Surgery

Outcome Measures

Primary Outcomes (1)

  • To determine whether a Phase III trial of acupuncture for postoperative recovery after colorectal surgery is warranted as defined by evidence of reduction of postoperative ileus when compared to sham acupuncture

    end of study

Secondary Outcomes (7)

  • To explore whether acupuncture improves patient satisfaction with the hospital experience by ameliorating other postoperative symptoms such as pain and nausea and vomiting

    daily pain score, opioids consumption (total dose of morphine equivalent during hospitalization and average dose per day) severity of nausea as defined by number of request for PRNantiemetics, and number of emetic episodes during hospital stay.

  • To determine the feasibility of a Phase III trial in terms of sample size, accrual rate, attrition rate and data completion

    end of study

  • GI-2, (also representing time to recovery of gastrointestinal [GI] function)

    patient first tolerated solid food,and time patient first passed a bowel movement

  • GI contractions measured with a multifunctional stethoscope

    duration of two minute before and immediately after each true or sham acupuncture treatment.

  • Daily pain score

    daily during hospitalization

  • +2 more secondary outcomes

Study Arms (2)

1

ACTIVE COMPARATOR

Acupuncture is the insertion of needles at certain body points.

Other: Acupuncture

2

SHAM COMPARATOR

sham acupuncture

Other: Sham Acupuncture

Interventions

Acupuncture will be given twice daily for a total of three days (Day 1 to 3). The two acupuncture sessions will be separated by at least 4 hours, preferably given in the morning and late afternoon. Each session will last approximately 30 minutes, starting from the moment the first needle is inserted and ending the moment the first needle is removed. The last treatment will be given at the end of Day 3 or day of discharge.

1

Sham Acupuncture involves the acupuncturist tapping a plastic guiding tube on the surface of the true points to produce some discernible sensation and then immediately tapping a real needle sideways parallel to the skin surface without needle insertion. It will be given twice daily for a total of three days (Day 1 to 3). The two acupuncture sessions will be separated by at least 4 hours, preferably given in the morning and late afternoon. Each session will last approximately 30 minutes, starting from the moment the first needle is inserted and ending the moment the first needle is removed. The last treatment will be given at the end of Day 3 or day of discharge,

2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men or women of any ethnicity
  • Age over 18 years (children are not included because colorectal cancer is rare in children).
  • Scheduled to undergo elective resection of biopsy proven colorectal cancer or suspected colorectal cancer

You may not qualify if:

  • Pre-operative factors:
  • History of major abdominal or pelvic surgery that have caused significant alteration in anatomy and function of the GI tract which may affect the endpoints of this study.
  • Laparoscopic procedures. They tend to result in less postoperative ileus.
  • Administration of epidural anesthetics or epidural opioids: these have previously been shown to affect postoperative GI motility. They made up only 5% of colectomy patients in the investigators' institution.
  • Acupuncture within the last 4 weeks (to exclude any possible residual effect from acupuncture)
  • Contraindications to use of electrical stimulation, including cardiac pacemaker and implantable cardioverter defibrillator (ICD)
  • Prior serious adverse event with acupuncture
  • Intra-operative events (these events alter the postoperative recovery course significantly):
  • Resection incorporating the upper GI tract. Such surgeries are usually more complex, involving more organs and are associated with a more diverse postoperative course, making the study population more heterogeneous.
  • Gross fecal spillage (high complication rate in this setting)
  • Need to leave nasogastric tube in (contaminating the primary endpoint)
  • Decision to give epidural anesthetics or epidural opioids postoperatively (shown previously to change the major endpoints)
  • Complications during surgery requiring a patient to be transferred to the Intensive Care Unit (ICU) directly from the Operating Room or Post Anesthesia Care Unit (PACU) as this also alters the postoperative course significantly. Patients transferred to the floor first will not be excluded. They will be fully registered and randomized. If they deteriorate later during the hospital stay, requiring a transfer to the ICU, they will still be followed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Sloan-Kettering Cancer Center 1275 York Avenue

New York, New York, 10021, United States

Location

Related Links

MeSH Terms

Conditions

Colonic NeoplasmsPain, PostoperativePostoperative Nausea and Vomiting

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsNauseaSigns and Symptoms, DigestiveVomiting

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Gary Deng, MD, PhD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2006

First Posted

November 23, 2006

Study Start

October 1, 2006

Primary Completion

February 1, 2013

Study Completion

February 1, 2013

Last Updated

October 12, 2015

Record last verified: 2015-10

Locations